No Data
No Data
Insider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics(NRIX.US) Officer Sells US$400.22K in Common Stock
$Nurix Therapeutics(NRIX.US)$ Officer van Houte Hans sold 20,000 shares of common stock on Jun 20, 2024 at an average price of $20.0108 for a total value of $400.22K.Source: Announcement What is state
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...
Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing
Hans van Houte, Chief Financial Officer, on June 20, 2024, sold 20,000 shares in Nurix Therapeutics (NRIX) for $400,216. Following the Form 4 filing with the SEC, Van Houte has control over a total of
Form 144 | Nurix Therapeutics(NRIX.US) Officer Proposes to Sell 368.8K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 20, $Nurix Therapeutics(NRIX.US)$ Officer JOHANNES VAN HOUTE intends to sell 20,000 shares of its common stock on Jun 20, with a total market value of approximately $368.8K
Piper Sandler Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35
Piper Sandler analyst Joseph Catanzaro maintains $Nurix Therapeutics(NRIX.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 39
No Data